Investor Presentaiton

Company overview Financial performance Oncology Financial review 2022 priorities Innovation: Pipeline overview Immunology Ophthalmology Appendix Innovation: Clinical trials Neuroscience Respiratory Disease Clinical Trials Update Includes selected ongoing or recently concluded global trials of Novartis development programs/products which are in confirmatory development or marketed (typically Phase 2b or later). For further information on all Novartis clinical trials, please visit: www.novartisclinicaltrials.com References Abbreviations Cardio-Renal Global Health Biosimilars 45 Investor Relations | Q2 2022 Results NOVARTIS | Reimagining Medicine

View entire presentation